FI814058L - Farmaceutiska foereningar framstaellning anvaendning och vid framstaellningen anvaendbara mellanprodukter samt deras framstaellning - Google Patents
Farmaceutiska foereningar framstaellning anvaendning och vid framstaellningen anvaendbara mellanprodukter samt deras framstaellningInfo
- Publication number
- FI814058L FI814058L FI814058A FI814058A FI814058L FI 814058 L FI814058 L FI 814058L FI 814058 A FI814058 A FI 814058A FI 814058 A FI814058 A FI 814058A FI 814058 L FI814058 L FI 814058L
- Authority
- FI
- Finland
- Prior art keywords
- framework
- pharmaceutical formulation
- video
- deras framstaellning
- samt deras
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
- C07C45/515—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an acetalised, ketalised hemi-acetalised, or hemi-ketalised hydroxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
- C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
- C07C45/60—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/74—Unsaturated compounds containing —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/30—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8040512 | 1980-12-18 | ||
| GB8040512 | 1980-12-18 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI814058L true FI814058L (fi) | 1982-06-19 |
| FI72510B FI72510B (fi) | 1987-02-27 |
| FI72510C FI72510C (fi) | 1987-06-08 |
Family
ID=10518062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI814058A FI72510C (fi) | 1980-12-18 | 1981-12-17 | Foerfarande foer framstaellning av terapeutiskt anvaendbara eterfoereningar. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4535183A (fi) |
| EP (1) | EP0054924B1 (fi) |
| JP (1) | JPS57145844A (fi) |
| DE (1) | DE3175083D1 (fi) |
| DK (1) | DK160866C (fi) |
| FI (1) | FI72510C (fi) |
| GB (1) | GB2090830B (fi) |
| GR (1) | GR76950B (fi) |
| HU (1) | HU190371B (fi) |
| IL (1) | IL64573A (fi) |
| IT (1) | IT1193786B (fi) |
| OA (1) | OA06998A (fi) |
| ZA (1) | ZA818741B (fi) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8318889D0 (en) * | 1983-07-13 | 1983-08-17 | Lilly Industries Ltd | Pharmaceutical compounds |
| US4887995A (en) * | 1985-01-22 | 1989-12-19 | University Of Pittsburgh | Method of treating sickle cell anemia |
| US4731381A (en) * | 1986-04-04 | 1988-03-15 | Merck & Co., Inc. | Method of treating a person for sickle cell anemia |
| IL98405A0 (en) * | 1990-06-11 | 1992-07-15 | Fmc Corp | Pharmaceutical compositions containing enzyme inhibiting agents |
| TW209866B (fi) * | 1991-03-20 | 1993-07-21 | Hoechst Ag | |
| US5872151A (en) * | 1992-10-01 | 1999-02-16 | Glaxo Wellcome Inc. | Immunopotentiatory agents and physiologically acceptable salts thereof |
| DE69306545T2 (de) * | 1992-10-01 | 1997-04-03 | Wellcome Found | Tucaresol als Mittel zur Immunopotentierung |
| US5958980A (en) * | 1993-08-26 | 1999-09-28 | Glaxo Wellcome, Inc. | Immunopotentiatory agent and physiologically acceptable salts thereof |
| US6068834A (en) * | 1994-03-04 | 2000-05-30 | The Procter & Gamble Company | Skin lightening compositions |
| BR9610207A (pt) * | 1995-08-28 | 1999-02-02 | American Home Prod | Acidos fenóxi acéticos como inibidores da aldose redutase e agentes anti-hiperglicêmicos |
| JP4316688B2 (ja) * | 1996-07-15 | 2009-08-19 | 日産化学工業株式会社 | 置換ビナフチル化合物及びその製造法 |
| AU7550398A (en) * | 1997-06-05 | 1998-12-21 | Takeda Chemical Industries Ltd. | Heterocyclic compounds, their production and use |
| WO2001070663A2 (en) * | 2000-03-17 | 2001-09-27 | Corixa Corporation | Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| JP4688315B2 (ja) * | 2001-02-28 | 2011-05-25 | メルシャン株式会社 | ４−デメトキシダウノマイシノンの製造 |
| US8198328B2 (en) * | 2004-01-21 | 2012-06-12 | New York University | Treatment of cancer using benzoic acid derivatives |
| AP2014007805A0 (en) * | 2011-12-28 | 2014-07-31 | Cytokinetics Inc The Regents Of The University Of California | Substituted benzaldehyde compounds and methods fortheir use in increasing tissue oxygenation |
| US9012450B2 (en) | 2011-12-28 | 2015-04-21 | Global Blood Therapeutics, Inc. | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
| SG11201507351PA (en) * | 2013-03-15 | 2015-10-29 | Global Blood Therapeutics Inc | Compounds and uses thereof for the modulation of hemoglobin |
| US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10100043B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
| US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
| SG10201802911RA (en) * | 2013-03-15 | 2018-05-30 | Global Blood Therapeutics Inc | Compounds and uses thereof for the modulation of hemoglobin |
| MX2015011769A (es) | 2013-03-15 | 2016-06-02 | Global Blood Therapeutics Inc | Compuestos y sus usos para modular la hemoglobina. |
| CA2902874C (en) * | 2013-03-15 | 2021-04-20 | Global Blood Therapeutics, Inc. | Substituted pyridinyl-6-methoxy-benzaldehyde derivatives and pharmaceutical compositions thereof useful for the modulation of hemoglobin |
| US9604999B2 (en) * | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| EP2970308B1 (en) | 2013-03-15 | 2021-07-14 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| PT3102208T (pt) | 2014-02-07 | 2021-04-05 | Global Blood Therapeutics Inc | Polimorfos cristalinos da base livre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3 il)metoxi)benzaldeído |
| WO2016043849A2 (en) * | 2014-07-24 | 2016-03-24 | Global Blood Therapeutics, Inc. | Compounds for treating acute respiratory distress syndrome or a negative effect thereof |
| KR102626155B1 (ko) | 2015-03-06 | 2024-01-17 | 비욘드스프링 파마수티컬스, 인코포레이티드. | Ras 돌연변이와 관련된 암의 치료 방법 |
| MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
| EP4011878A1 (en) | 2015-07-13 | 2022-06-15 | Beyondspring Pharmaceuticals, Inc. | Plinabulin compositions |
| BR112018011272A2 (pt) | 2015-12-04 | 2018-11-21 | Global Blood Therapeutics Inc | regimes de dosagem para 2-hidróxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3-il)metóxi)benzaldeído |
| CA3013467A1 (en) | 2016-02-08 | 2017-08-17 | Beyondspring Pharmaceuticals, Inc. | Compositions containing tucaresol or its analogs |
| TWI752307B (zh) | 2016-05-12 | 2022-01-11 | 美商全球血液治療公司 | 新穎化合物及製造化合物之方法 |
| KR20230018545A (ko) | 2016-06-06 | 2023-02-07 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 호중구감소증을 줄이는 조성물 및 방법 |
| TWI778983B (zh) | 2016-10-12 | 2022-10-01 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
| JP2020503363A (ja) | 2017-01-06 | 2020-01-30 | ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド | チューブリン結合化合物およびその治療的使用 |
| KR20190109479A (ko) | 2017-02-01 | 2019-09-25 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 호중구감소증의 감소 방법 |
| JP7350015B2 (ja) | 2018-01-24 | 2023-09-25 | ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド | プリナブリンの投与による血小板減少症を軽減するための組成物および方法 |
| EP3860975B1 (en) | 2018-10-01 | 2023-10-18 | Global Blood Therapeutics, Inc. | Modulators of hemoglobin for the treatment of sickle cell disease |
| MX2021005887A (es) | 2018-11-19 | 2021-09-14 | Global Blood Therapeutics Inc | Compuestos de 2-formil-3-hidroxifeniloximetilo capaces de modular hemoglobina. |
| CN112778155B (zh) * | 2019-11-11 | 2023-08-11 | 大连万春布林医药有限公司 | 妥卡雷琐衍生物及其用途 |
| CN115636742B (zh) * | 2022-11-11 | 2024-04-09 | 江西亚太科技发展有限公司 | 一种重结晶的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR71054E (fr) * | 1957-02-19 | 1959-10-08 | Rhone Poulenc Sa | Nouveaux dérivés phénoxycarboxyliques |
| FR1186520A (fr) * | 1957-11-18 | 1959-08-26 | Rhone Poulenc Sa | Nouvelles compositions phytohormonales |
| CH543472A (fr) * | 1969-01-31 | 1973-10-31 | Orchimed Sa | Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques |
| JPS5851972B2 (ja) * | 1976-05-14 | 1983-11-19 | 昭和化学工業株式会社 | １，４−ビス−スチリルベンゼン誘導体およびその製法 |
| JPS5649335A (en) * | 1979-06-29 | 1981-05-02 | Wellcome Found | Ether compound |
-
1981
- 1981-12-17 IT IT49937/81A patent/IT1193786B/it active
- 1981-12-17 HU HU813807A patent/HU190371B/hu unknown
- 1981-12-17 EP EP81110553A patent/EP0054924B1/en not_active Expired
- 1981-12-17 DE DE8181110553T patent/DE3175083D1/de not_active Expired
- 1981-12-17 FI FI814058A patent/FI72510C/fi not_active IP Right Cessation
- 1981-12-17 IL IL64573A patent/IL64573A/xx not_active IP Right Cessation
- 1981-12-17 GR GR66822A patent/GR76950B/el unknown
- 1981-12-17 ZA ZA818741A patent/ZA818741B/xx unknown
- 1981-12-17 DK DK561881A patent/DK160866C/da not_active IP Right Cessation
- 1981-12-17 GB GB8138086A patent/GB2090830B/en not_active Expired
- 1981-12-17 JP JP56204493A patent/JPS57145844A/ja active Granted
- 1981-12-18 US US06/332,246 patent/US4535183A/en not_active Expired - Lifetime
-
1982
- 1982-01-16 OA OA57595A patent/OA06998A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IT1193786B (it) | 1988-08-24 |
| IL64573A (en) | 1985-04-30 |
| OA06998A (fr) | 1983-08-31 |
| GR76950B (fi) | 1984-09-04 |
| EP0054924A3 (en) | 1982-09-22 |
| GB2090830A (en) | 1982-07-21 |
| FI72510B (fi) | 1987-02-27 |
| FI72510C (fi) | 1987-06-08 |
| EP0054924A2 (en) | 1982-06-30 |
| ZA818741B (en) | 1983-07-27 |
| IL64573A0 (en) | 1982-03-31 |
| DK160866B (da) | 1991-04-29 |
| EP0054924B1 (en) | 1986-08-06 |
| GB2090830B (en) | 1984-09-26 |
| DK561881A (da) | 1982-06-19 |
| US4535183A (en) | 1985-08-13 |
| IT8149937A0 (it) | 1981-12-17 |
| JPH0249294B2 (fi) | 1990-10-29 |
| DK160866C (da) | 1991-10-14 |
| HU190371B (en) | 1986-08-28 |
| DE3175083D1 (en) | 1986-09-11 |
| JPS57145844A (en) | 1982-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI814058L (fi) | Farmaceutiska foereningar framstaellning anvaendning och vid framstaellningen anvaendbara mellanprodukter samt deras framstaellning | |
| FI811745L (fi) | Farmaceutisk komposition och foerfarande foer framstaellning daerav | |
| FI823561L (fi) | Foerbaettringar vid en steroidfoerening och denna innehaollande farmaceutiska produkter | |
| FI820178L (fi) | Fosforylfoereningar foerfarande foer deras framstaellning dessa foereningar innehaollande farmaceutiska preparat samt deras anvaendning | |
| FI831740L (fi) | Foerfarande foer framstaellning av ett seskviterpenlaktonhaltigt farmaceutiskt extrakt | |
| MY8600353A (en) | Pharmaceutical formulation | |
| FI822670A0 (fi) | Ergopeptinderivat, foerfaranden foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning vid terapeutisk behandling | |
| FI834735A0 (fi) | Foerfarande foer framstaellning av farmaceutiskt aktiva pyridinderivat | |
| FI793619A (fi) | Foerfarande och anordning foer angivande av traeffpunkten vid en maolskjutningstavla | |
| FI821100A0 (fi) | Foerfarande foer framstaellning av jaesta alkoholprodukter | |
| FI773346A (fi) | Foerfarande foer framstaellning av farmaceutiskt anvaendbara aminopropanolderivat | |
| IT1124572B (it) | Sistema per la trasmissione di medicinale in microparticelle | |
| FI801668A (fi) | Foerfarande foer framstaellning av maenniskointerferon | |
| DK173081A (da) | Farmaceutisk produkt til oral administration indeholdende cytidindiphosphocholin | |
| FI820848L (fi) | Foerfarande foer att foerhindra slirning eller glidning mellan drivhjul och underlag vid saerskilt fleraxliga fordonsdrivsystem med hydrostatisk kraftoeverfoering | |
| FI823360A0 (fi) | Nya 3-fenyl-1-indanaminer och foerfarande foer deras framstaellning samt farmaceutiska kompositionerinnehaollande dessa | |
| FI834736A0 (fi) | Foerfarande foer framstaellning av farmaceutiskt aktiva pyridinderivat | |
| FI823820A0 (fi) | Anordning vid skruv-mutterkombinationer och monteringsverktyg haerfoer | |
| FI811127L (fi) | Anordning vid pressar foer avvattning av material | |
| FI811922L (fi) | Heterocykliska foereningar deras framstaellning och farmaceutiska kompositioner som innehaoller dessa | |
| FI812253L (fi) | Ergolinderivat foerfarande foer deras framstaellning dessa innehaollande farmaceutiska foereningar och deras anvaendning vid terapeutisk behandling | |
| FI821263L (fi) | Saett och anordning vid fallrepstrappor | |
| FI823493A0 (fi) | Foerfarande och anordning vid behandling av ledning och kabel | |
| FI800481A (fi) | Foerfarande foer framstaellning av substituerade acylpiperidiner | |
| HK90087A (en) | Pharmaceutical formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |
Owner name: THE WELLCOME FOUNDATION LIMITED |